Maintelyte

Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydrate, the active ingredients in Maintelyte, is an IV electrolyte solution presented as a solution for injection for intravenous use. It restores electrolyte balance and provides fluid volume in patients who need fluid and electrolyte replacement. GNH USA supplies Maintelyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Maintelyte is used to correct fluid and electrolyte disturbances in a range of clinical settings. - Dehydration: restores intravascular volume and corrects electrolyte deficits. - Hypovolemia after surgery: provides rapid plasma expansion and maintains hemodynamic stability. - Electrolyte imbalance (e.g., low potassium or magnesium): supplies essential ions to normalize serum concentrations. - Severe diarrhea or vomiting: replaces lost fluids and electrolytes to prevent shock.

Adverse reactions may occur with any intravenous solution.

Common Side Effects: - Infusion site pain or irritation. - Mild hyperkalemia. - Mild hypermagnesemia. - Transient hypotension. - Nausea. - Headache.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia. - Severe hypermagnesemia causing respiratory depression. - Anaphylactic or severe allergic reaction. - Metabolic acidosis. - Fluid overload with pulmonary edema. - Cardiac arrhythmias unrelated to electrolyte levels.

Clinicians should observe specific safety measures when using Maintelyte. - Assess baseline electrolyte levels: obtain serum potassium, magnesium, and sodium before infusion. - Monitor cardiac rhythm: continuous ECG monitoring is advised during rapid infusion. - Adjust infusion rate in renal impairment: slower rates reduce risk of accumulation. - Avoid use in patients with existing hyperkalemia: may exacerbate potassium excess. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Maintelyte may interact with other medications that affect electrolyte balance or cardiac function.

Major Interactions (Avoid): - Concurrent IV potassium‑containing solutions: risk of severe hyperkalemia. - Simultaneous magnesium supplements: risk of hypermagnesemia. - ACE inhibitors or ARBs: may increase serum potassium.

Moderate Interactions (Monitor Closely): - Loop or thiazide diuretics: can alter electrolyte levels, requiring monitoring. - Digoxin: serum potassium changes affect digoxin toxicity. - Insulin therapy: may cause rapid intracellular potassium shift, necessitating careful electrolyte monitoring.